Almac adds language-based pack unit for niche and orphan drugs

Related tags Pharmacology Almac

Almac says new late-stage customisation suite at its facility will cater for firms wishing to launch orphan and niche drugs in Europe.

The unit, in Craigavon, Northern Ireland, will produce ‘regional’ packs for European markets that share a common language, which will offer significant benefits according to Almac distribution manager Mark English.

Grouping countries by language allowing for multi-language packs to service multiple markets, with country specific information added at point of despatch, provides significant cost advantages.

He added that: “Working with products that are manufactured in very low volumes at, often, a very high cost means that solutions to minimise stock holding are of particular benefit​.”

Almac's investment is timely given that, increasingly drugmakers are focused on developing niche, high-value pharmaceutical products, the correct storage and appropriate distribution of which is critical.

Related news

Show more

Related products

show more

Enhance your cGMP chemical supply chain

Enhance your cGMP chemical supply chain

Thermo Fisher Scientific – Production Chemicals and Services | 17-Jan-2023 | Technical / White Paper

Supply chain issues have real, quantifiable impacts on biomanufacturers. However, the right support can make a cGMP supply chain operate seamlessly. Thermo...

Understanding the hidden value of quality

Understanding the hidden value of quality

Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | Technical / White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Related suppliers

Follow us

Products

View more

Webinars